DeepHealth Launches Reporting Pro, Bringing AI Automation to Radiology Reporting

SOMERVILLE, Mass., June 10, 2026 (GLOBE NEWSWIRE) --  DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced the launch of Reporting Pro, a next-generation AI-powered solution designed to transform the way radiologists generate clinical reports and findings for their referring physicians.

GlobeNewsWire • Jun 10, 2026

RadNet Secures $250 Million Incremental Term Loan to Fund Strategic Growth Opportunities and Reduces the Interest Rates on its Credit Facility by 0.25%

LOS ANGELES, June 10, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of outpatient imaging centers and a premier developer of radiology digital health solutions, today announced that it has entered into Incremental Amendment No. 3 (the “Third Amendment”) to its Third Amended and Restated First Lien Credit and Guaranty Agreement, as amended (the “Existing Credit Agreement” and, as amended by the Third Amendment, the “Credit Agreement”).

GlobeNewsWire • Jun 10, 2026

RadNet Announces a Proposed $200 Million Incremental Term Loan to Fund Strategic Growth Opportunities

LOS ANGELES, June 03, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of outpatient imaging centers and a premier developer of radiology digital health solutions, today announced that it seeks to secure an incremental term loan in the aggregate principal amount of $200 million (the “Proposed 2026 Incremental Term Loan”) pursuant to a proposed amendment (the “Proposed Amendment”) to its Third Amended and Restated First Lien Credit and Guaranty Agreement, as amended (the “Existing Credit Agreement” and, the transaction, the “Loan Transaction”). If consummated, the Proposed 2026 Incremental Term Loan would be added to and form a part of the existing term loan under the Existing Credit Agreement (the “Existing Term Loan”).

GlobeNewsWire • Jun 3, 2026

Do Options Traders Know Something About RadNet Stock We Don't?

Investors need to pay close attention to RDNT stock based on the movements in the options market lately.

Zacks Investment Research • Jun 2, 2026

RadNet to Host Men's Health Webinar on June 13, 2026

RadNet hosts free webinar for Men's Health Month, featuring live Q&A and physicians presenting on coronary artery disease, prostate cancer and lung cancer.

GlobeNewsWire • May 28, 2026

Jefferies updates its list of highest-conviction Buy-rated stocks

Jefferies, an investment banking and capital management firm, has updated its ‘Franchise Picks' list, which features the company's highest-conviction ‘Buy' rated stocks.

Finbold • May 18, 2026

RadNet, Inc. (RDNT) Q1 2026 Earnings Call Transcript

RadNet, Inc. (RDNT) Q1 2026 Earnings Call Transcript

Seeking Alpha • May 12, 2026

RadNet Q1 Earnings Call Highlights

RadNet NASDAQ: RDNT reported record first-quarter 2026 revenue and adjusted EBITDA, with management saying demand for advanced imaging and the growing contribution of its Digital Health business helped offset severe winter weather disruptions on the East Coast.

MarketBeat • May 11, 2026

RadNet Reports Record First Quarter Financial Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow

LOS ANGELES, May 10, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 435 outpatient imaging centers and a premier developer of radiology digital health solutions, today reported financial results for its first quarter of 2026.

GlobeNewsWire • May 10, 2026

Will RadNet (RDNT) Report Negative Earnings Next Week? What You Should Know

RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • May 4, 2026